Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (10)

2009

  1. Loss of the LAT Adaptor Converts Antigen-Responsive T Cells into Pathogenic Effectors that Function Independently of the T Cell Receptor

    Immunity, Vol. 31, Núm. 2, pp. 197-208

2007

  1. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: Insights into the mechanism of PLCγ2 activation

    Blood, Vol. 110, Núm. 7, pp. 2466-2474

2005

  1. Autistic effector T cells in mice with a point mutation in the LAT adaptor fail to respond to Listeria monocytogenes infection

    International Immunology, Vol. 17, Núm. 7, pp. 951-957

  2. The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse αβ- and γδ effector T cells

    Journal of Immunology, Vol. 175, Núm. 2, pp. 713-719

2003

  1. LAT regulates γδ T cell homeostasis and differentiation

    Nature Immunology, Vol. 4, Núm. 10, pp. 999-1008

  2. Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of αiib/β3

    Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 2, pp. 320-329

2002

  1. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor

    Science, Vol. 296, Núm. 5575, pp. 2036-2040

  2. Non-T cell activation linker (NTAL): A transmembrane adaptor protein involved in immunoreceptor signaling

    Journal of Experimental Medicine, Vol. 196, Núm. 12, pp. 1617-1626

1999

  1. Functional expression of CD43 on human natural killer cells

    Journal of Leukocyte Biology, Vol. 66, Núm. 6, pp. 923-929

1996

  1. Arterial hypertension in the adult population of Guadeloupe, and associated factors in subjects of African origin

    Revue d'Epidemiologie et de Sante Publique, Vol. 44, Núm. 5, pp. 417-426